Heilongjiang ZBD Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,630.014 million compared to CNY 1,363.061 million a year ago. Operating income was CNY 347.665 million compared to CNY 232.072 million a year ago. Net income was CNY 276.272 million compared to CNY 184.458 million a year ago. Basic earnings per share from continuing operations was CNY 0.3253 compared to CNY 0.2172 a year ago.